Patient collective with ADM-implementation.
|ADM||Product||Number of ADM implants used||Number of treated patients||Avg. patient age (years)||Avg. follow-up time (months)|
|HADM||Epiflex/DIZG||15||12||46 (36–76)||40 (20–50)|
|PADM||Strattice/LifeCell||21||16||56 (44–66)||43 (30–54)|
|BADM||Tutomesh/RTI Surgical||16||13||53 (33–74)||20 (12–31)|
|Total||All ADMs||52||41||52 (33–76)||36 (12–54)|
|Listing of matrix, name of ADM-product and its fabricant, amount of breast reconstructions (BR)/augmentations with usage of ADMs, number of patients treated with ADMs, average patient age and range in years, and average follow-up time + range in months of the given patient collective, which received a breast reconstruction with ADM; HADM: human ADM, PADM: porcine ADM, and BADM: bovine ADM.|